Evidence map›Paper›PMID 31521948›Full record

ArticleNeoplasia (New York, N.Y.)2019

Microenvironmental Factors Drive Tenascin C and Src Cooperation to Promote Invadopodia Formation in Ewing Sarcoma.

Allegra G Hawkins, Claire M Julian, Sonja Konzen, Sydney Treichel, Elizabeth R Lawlor, Kelly M Bailey

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Spatial Profiling Identifies Tumor-Associated Stroma Enrichment and MIF as Potential Immunotherapy Targets in Primary Ewing Sarcomas.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Allegra G HawkinsDepartment of Pediatrics, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA, 48109.
Claire M JulianDepartment of Pediatrics, Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA 15224.
Sonja KonzenDepartment of Pediatrics, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA, 48109.
Sydney TreichelDepartment of Pediatrics, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA, 48109.
Elizabeth R LawlorDepartment of Pediatrics, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA, 48109.
Kelly M BaileyDepartment of Pediatrics, Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA 15224. Electronic address: Kelly.Bailey@chp.edu.
University of Michigan–Ann Arbor · USUniversity of Pittsburgh · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
Tissue and Pathology ResourcesU54CA168512 · NCI · SARC · PI BAKER, LAURENCE HOWARD, POLLOCK, RAPHAEL E. · 2012 to 2016
$11.0M
Training Program in Molecular HematologyT32HL007622 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SUNG WON CHOI, Jordan A. Shavit · 1986 to 2026
$9.2M
Training Program in Tumor MicroenvironmentT32CA009676 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Maria G Castro, Analisa Virginia DiFeo · 1992 to 2026
$7.3M
Molecular Basis of Pediatric DiseaseK12HD052892 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TERENCE S. DERMODY · 2007 to 2026
$6.5M
Proteogenomics of Cancer Training ProgramT32CA140044 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAO, ARVIND, SARTOR, MAUREEN AGNES · 2010 to 2024
$3.9M
Investigating Wnt/beta-catenin dependent tumor-microenvironment interactions that contribute to metastasis in Ewing sarcomaK00CA234810 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI HAWKINS, ALLEGRA GRACIANA · 2019 to 2020
$172k
Investigating Wnt/beta-catenin dependent tumor-microenvironment interactions that contribute to metastasis in Ewing sarcomaF99CA234810 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAWKINS, ALLEGRA GRACIANA · 2018 to 2018
$45k
NCI NIH HHS F99 CA234810NCI NIH HHS K00 CA234810NCI NIH HHS P30 CA046592NCI NIH HHS T32 CA009676NCI NIH HHS T32 CA140044NCI NIH HHS U54 CA168512NHLBI NIH HHS T32 HL007622NICHD NIH HHS K12 HD052892
6 · The paper itself

Abstract

Ewing sarcoma is a bone tumor most commonly diagnosed in adolescents and young adults. Survival for patients with recurrent or metastatic Ewing sarcoma is dismal and there is a dire need to better understand the mechanisms of cell metastasis specific to this disease. Our recent work demonstrated that microenvironmental stress leads to increased Ewing sarcoma cell invasion through Src activation. Additionally, we have shown that the matricellular protein tenascin C (TNC) promotes metastasis in Ewing sarcoma. A major role of both TNC and Src is mediation of cell-cell and cell-matrix interactions resulting in changes in cell motility, invasion, and adhesion. However, it remains largely unknown, if and how, TNC and Src are linked in these processes. We hypothesized that TNC is a positive regulator of invadopodia formation in Ewing sarcoma through its ability to activate Src. We demonstrate here that both tumor cell endogenous and exogenous TNC can enhance Src activation and invadopodia formation in Ewing sarcoma. We found that microenvironmental stress upregulates TNC expression and this is dampened with application of the Src inhibitor dasatinib, suggesting that TNC expression and Src activation cooperate to promote the invasive phenotype. This work reports the impact of stress-induced TNC expression on enhancing cell invadopodia formation, provides evidence for a feed forward loop between TNC and Src to promote cell metastatic behavior, and highlights a pathway by which microenvironment-driven TNC expression could be therapeutically targeted in Ewing sarcoma.

Indexed as

Tumor MicroenvironmentCell Line, TumorCells, CulturedDasatinibGene ExpressionGene Expression ProfilingHumansImmunohistochemistryModels, BiologicalPhosphorylationPodosomesSarcoma, Ewingsrc-Family KinasesStress, PhysiologicalTenascinWnt ProteinsDasatinibsrc-Family KinasesTenascinTNC protein, humanWnt Proteins

Identifiers

PMID31521948
PMCPMC6745492
OpenAlexW2972715104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.